AAAAAA
Results:
1-8
|
Results: 8
Authors:
Baumhakel, M
Kasel, D
Rao-Schymanski, RA
Bocker, R
Beckurts, KT
Zaigler, M
Barthold, D
Fuhr, U
Citation: M. Baumhakel et al., Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes, INT J CL PH, 39(12), 2001, pp. 517-528
Authors:
Zaigler, M
Rietbrock, S
Szymanski, J
Dericks-Tan, JSE
Staib, AH
Fuhr, U
Citation: M. Zaigler et al., Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women, INT J CL PH, 38(5), 2000, pp. 235-244
Authors:
Wilde, S
Jetter, A
Menzel, H
Rietbrock, S
Zaigler, M
Sieber, M
Tesch, H
Hempel, G
Reif, S
Jaehde, U
Merkel, U
Johnson, S
Diehl, V
Fuhr, U
Citation: S. Wilde et al., Population pharmacokinetics of drugs in the BEACOPP chemotherapy regimen used in Hodgkin's disease, INT J CL PH, 38(3), 2000, pp. 147-149
Authors:
Zaigler, M
Tantcheva-Poor, I
Fuhr, U
Citation: M. Zaigler et al., Problems and perspectives of phenotyping for drug-metabolizing enzymes in man, INT J CL PH, 38(1), 2000, pp. 1-9
Authors:
Tantcheva-Poor, I
Zaigler, M
Rietbrock, S
Fuhr, U
Citation: I. Tantcheva-poor et al., Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test (vol 9, pg 131, 1999), PHARMACOGEN, 9(6), 1999, pp. 781-781
Authors:
Tantcheva-Poor, I
Zaigler, M
Rietbrock, S
Fuhr, U
Citation: I. Tantcheva-poor et al., Estimation of cytochrome P-450CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test, PHARMACOGEN, 9(2), 1999, pp. 131-144
Authors:
Rost, KL
Fuhr, U
Thomsen, T
Zaigler, M
Brockmoller, J
Bohnemeier, H
Roots, I
Citation: Kl. Rost et al., Omeprazole weakly inhibits CYP1A2 activity in man, INT J CL PH, 37(11), 1999, pp. 567-574
Authors:
Kinzig-Schippers, M
Fuhr, U
Zaigler, M
Dammeyer, J
Rusing, G
Labedzki, A
Bulitta, J
Sorgel, F
Citation: M. Kinzig-schippers et al., Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2, CLIN PHARM, 65(3), 1999, pp. 262-274
Risultati:
1-8
|